Provided By GlobeNewswire
Last update: Mar 7, 2025
WARREN, N.J., March 07, 2025 (GLOBE NEWSWIRE) -- Mittul Mehta, Chief Information Officer & Head of Tevogen.AI at Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, recently joined industry leaders at Proskauer’s AI discussion panel, "Attuned AI: Shaping AI to Empower Your Industry," held on March 6, 2025, in New York City.
Read more at globenewswire.comNASDAQ:TVGNW (3/7/2025, 8:00:01 PM)
0.0669
0 (-4.29%)
1.14
+0.04 (+3.64%)
Find more stocks in the Stock Screener
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.